| Financial Year |
March 31 2023 |
| Monetary Funds |
239,201,768.63 |
| Held-for-trading Financial Assets |
30,147,945.21 |
| Notes Receivable |
32,966,177.26 |
| Accounts Receivable |
170,282,448.45 |
| Advances to Suppliers |
8,076,386.05 |
| Other Receivables |
731,791.62 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
223,204,520.49 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
56,171,465.16 |
| Total Current Assets |
804,940,719.74 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,056,551,055.92 |
| Under-construction Projects |
478,677,572.71 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
44,875,131.12 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
15,613,916.15 |
| Deferred Income Tax Assets |
35,115,644.80 |
| Other Non-Current Assets |
76,547,070.99 |
| Sub-Total of Non-Current Assets |
1,708,568,648.85 |
| Total Assets |
2,513,509,368.59 |
| Short-Term Loans |
267,131,451.98 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
55,144,169.56 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
21,803,983.39 |
| Taxes Payable |
3,919,452.23 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
61,946,257.02 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
359,492,761.08 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
770,435,063.35 |
| Long-term Loans |
139,030,545.51 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
237,800,152.33 |
| Total Liabilities |
1,008,235,215.68 |
| Paid-In Capital(Or Share Stock) |
884,800,000.00 |
| Capital Surplus |
327,139,132.68 |
| Surplus Reserve |
84,702,066.10 |
| LESS:Treasury Stock |
29,226,758.00 |
| Undistributed Profits |
237,590,014.25 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,505,274,152.91 |
| Owner's Equity（Stockholder's Equity） |
1,505,274,152.91 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,513,509,368.59 |
